Application of Indinavir sulfate in preparation of medicaments for preventing or treating ischemic cardiovascular and cerebrovascular diseases
The invention relates to new uses of medicaments and particularly relates to an application of Indinavir sulfate in the prevention or treatment of ischemic cardiovascular and cerebrovascular diseases through inhibiting the expression of HMGB1 (High Mobility Group Box 1). According to the application...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to new uses of medicaments and particularly relates to an application of Indinavir sulfate in the prevention or treatment of ischemic cardiovascular and cerebrovascular diseases through inhibiting the expression of HMGB1 (High Mobility Group Box 1). According to the application, the range of oral dosage is 120-6,000mg and preferably is 120-3,000mg; the range of injection dosage is 30-2,000mg and preferably is 30-1,000mg. |
---|